Abstract Submission Guidelines

Please read the submission rules before submitting an abstract.
  • Abstracts, in the prescribed format should be emailed to abstract.ishicon2025@gmail.com
  • Deadline for abstract submission is 15th October, 2025.
  • Abstracts must be received by the announced deadline. Abstracts received after the deadline will not be considered.
  • Abstracts may be submitted for oral presentation or poster presentation.
  • A selected number of abstracts will be invited for oral presentation. Rest of the abstracts will be called for poster presentation.
    The list of selected abstracts for oral presentation will be finalized by 16th October, 2025, and selected candidate will also be informed via email.
  • Presenting authors must be registered participants. Only abstracts of authors who have paid their registration fees will be scheduled for presentation and included for publication.
  • A single attendee can act as the presenting author for a maximum of 5 abstracts.
  • By submitting an abstract, you acknowledge your consent for it to be published in the official meeting publication.
  • All abstracts should be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university specific publications office (or other similar facility) or by a copy editor, prior to submission.
  • The submitter should have ensure that the patient consent is obtained before submitting the abstract.
  • Only abstracts with results will be accepted for review. Abstracts stating “data will be discussed in the presentation” will NOT be accepted.
  • The Scientific Committee will make the final decision as to whether the abstract will be accepted for presentation, with consideration given to the author’s preference.
  • Academic titles should not be used in author names.
  • Abstract structure – abstracts should clearly state:
  • Research/Medical Abstracts should follow this structure:
    • Background/Aims
    • Materials and Methods
    • Results
    • Discussion and conclusion
  • Case Reports/Clinical Cases should follow this structure:
    • Background
    • Case description
    • Clinical hypothesis
    • Diagnostic pathway
    • Discussion and learning points
  • The abstract must not exceed 250 words including references. Title, authors’ names, affiliations and tables and figures are not included in the word count.
  • Tables and Figures must be referenced in the text and numbered in the order they appear. All tables and figure must be accompanied by a caption and list of abbreviations whenever appropriate (e.g., Figure 1: description /Table 1: description).
  • Font:Times New Roman (12 size, Title in Bold)
  • Authors’ Name: Full Names, Name of the presenting author should be underlined
  • Email : Email id of presenting author
  • The authors’ affiliation should be clearly indicated as follows: Department, Institution, City, Country (e.g., Department of XXXXX, University of XXXX, India). Please note that the country names should be spelled in English.
  • Abstract title – must be in UPPER CASE and limited to 25 words. Please submit symbols as words. e.g. Beta, alpha, etc.
  • You may enter up to 3 keywords, separated by commas (e.g., word 1, word 2, word 3)
  • Abbreviations and acronyms should be spelled in full and followed by the abbreviation/acronym in a parenthesis the first time they are mentioned in the abstract. E.g. Systemic lupus erythematosus (SLE) is a rare disease. SLE was diagnosed in 5 out of 10 patients…
  • Use generic names of drugs in small letters and not trade names. Abstract content must be scientifically valid, objective and balanced and contain no commercial promotional content.
  • Do not include patient names within the text or figures, as well as any hospital patient ID codes or other details that could potentially reveal patient identities. Figures showing patients faces should be modified and at least eyes should be covered or blurred.
Abstract Categories
  1. Research/Medical Abstracts
  2. Case Reports/Clinical Cases
Submission Confirmation
  • After submission of the abstract, a confirmation email will be sent to the participant. In order to receive confirmation, please ensure that emails from abstract.ishicon2025@gmail.com are not marked as spam by your e-mail provider.
  • A confirmation message will be sent to the corresponding author’s e-mail address after the abstract submission is completed. Please keep this confirmation email. If this email doesn’t appear, check your spam folder.
  • In case you do not receive the confirmatory email within 24 Hour of submission, kindly drop a query at: abstract.ishicon2025@gmail.com, or contact the organizing secretary.
  • If you have not received confirmation that your abstract has been submitted, please contact us. Do not submit multiple copies of the same abstract.